Suppr超能文献

为体弱老年女性进行乳腺钼靶筛查:负担有哪些?

Screening mammography for frail older women: what are the burdens?

作者信息

Walter L C, Eng C, Covinsky K E

机构信息

Division of Geriatrics, San Francisco VA Medical Center and the University of California-San Francisco 94121, USA.

出版信息

J Gen Intern Med. 2001 Nov;16(11):779-84. doi: 10.1111/j.1525-1497.2001.10113.x.

Abstract

OBJECTIVE

The potential benefits and harms of screening mammography in frail older women are unknown. Therefore, we studied the outcomes of a screening mammography policy that was instituted in a population of community-living nursing home-eligible women as a result of requirements of state auditors. We focused on the potential burdens that may be experienced.

METHODS

Between January 1995 and December 1997, we identified 216 consecutive women who underwent screening mammography after enrolling in a program designed to provide comprehensive care to nursing home-eligible patients who wished to stay at home. Mammograms were performed at 4 radiology centers. From computerized medical records, we tracked each woman through September 1999 for performance and results of mammography, additional breast imaging and biopsies, documentation of psychological reactions to screening, as well as vital status. Mean follow-up was 2.6 years.

RESULTS

The mean age of the 216 women was 81 years. Sixty-three percent were Asian, 91% were dependent in at least 1 activity of daily living, 49% had cognitive impairment, and 11% died within 2 years. Thirty-eight women (18%) had abnormal mammograms requiring further work-up. Of these women, 6 refused work-up, 28 were found to have false-positive mammograms after further evaluation, 1 was diagnosed with ductal carcinoma in situ (DCIS), and 3 were diagnosed with local breast cancer. The woman diagnosed with DCIS and 1 woman diagnosed with breast cancer were classified as not having benefited, because screening identified clinically insignificant disease that would not have caused symptoms in the women's lifetimes, since these women died of unrelated causes within 2 years of diagnosis. Therefore, 36 women (17%; 95% confidence interval [CI], 12 to 22) experienced burden from screening mammography (28 underwent work-up for false-positive mammograms, 6 refused further work-up of an abnormal mammogram, and 2 had clinically insignificant cancers identified and treated). Forty-two percent of these women had chart-documented pain or psychological distress as a result of screening. Two women (0.9%; 95% CI, 0 to 2) may have received benefit from screening mammography.

CONCLUSION

We conclude that screening mammography in frail older women frequently necessitates work-up that does not result in benefit, raising questions about policies that use the rate of screening mammograms as an indicator of the quality of care in this population. Encouraging individualized decisions may be more appropriate and may allow screening to be targeted to older women for whom the potential benefit outweighs the potential burdens.

摘要

目的

筛查性乳腺钼靶检查对体弱老年女性的潜在益处和危害尚不清楚。因此,我们研究了一项筛查性乳腺钼靶检查政策的结果,该政策因州审计员的要求而在符合入住养老院条件的社区居住女性群体中实施。我们关注的是可能经历的潜在负担。

方法

在1995年1月至1997年12月期间,我们确定了216名连续的女性,她们在参加一个旨在为希望居家的符合入住养老院条件的患者提供全面护理的项目后接受了筛查性乳腺钼靶检查。乳腺钼靶检查在4个放射中心进行。从计算机化医疗记录中,我们追踪了每位女性直至1999年9月,以了解乳腺钼靶检查的执行情况和结果、额外的乳房影像学检查和活检、对筛查的心理反应记录以及生命状态。平均随访时间为2.6年。

结果

这216名女性的平均年龄为81岁。63%为亚洲人,91%至少在一项日常生活活动中存在依赖,49%有认知障碍,11%在2年内死亡。38名女性(18%)的乳腺钼靶检查结果异常,需要进一步检查。在这些女性中,6人拒绝进一步检查,28人在进一步评估后被发现乳腺钼靶检查结果为假阳性,1人被诊断为导管原位癌(DCIS),3人被诊断为局部乳腺癌。被诊断为DCIS的女性和1名被诊断为乳腺癌的女性被归类为未受益,因为筛查发现的是临床上无意义的疾病,在这些女性的一生中不会引起症状,因为这些女性在诊断后2年内死于无关原因。因此,36名女性(17%;95%置信区间[CI],12至22)因筛查性乳腺钼靶检查而承受负担(28人因假阳性乳腺钼靶检查结果接受了进一步检查,6人拒绝了对异常乳腺钼靶检查结果的进一步检查,2人被发现并治疗了临床上无意义的癌症)。这些女性中有42%因筛查而有病历记录的疼痛或心理困扰。两名女性(0.9%;95%CI,0至2)可能从筛查性乳腺钼靶检查中受益。

结论

我们得出结论,体弱老年女性的筛查性乳腺钼靶检查常常需要进行一些并无益处的进一步检查,这引发了对将筛查性乳腺钼靶检查率用作该人群医疗质量指标的政策的质疑。鼓励个体化决策可能更为合适,并且可以使筛查针对那些潜在益处超过潜在负担的老年女性。

相似文献

1
Screening mammography for frail older women: what are the burdens?
J Gen Intern Med. 2001 Nov;16(11):779-84. doi: 10.1111/j.1525-1497.2001.10113.x.
2
Weighing the benefits and burdens of mammography screening among women age 80 years or older.
J Clin Oncol. 2009 Apr 10;27(11):1774-80. doi: 10.1200/JCO.2008.19.9877. Epub 2009 Mar 2.
3
Decreasing women's anxieties after abnormal mammograms: a controlled trial.
J Natl Cancer Inst. 2004 Apr 7;96(7):529-38. doi: 10.1093/jnci/djh083.
4
Ten-year risk of false positive screening mammograms and clinical breast examinations.
N Engl J Med. 1998 Apr 16;338(16):1089-96. doi: 10.1056/NEJM199804163381601.
5
6
Systematic review: the long-term effects of false-positive mammograms.
Ann Intern Med. 2007 Apr 3;146(7):502-10. doi: 10.7326/0003-4819-146-7-200704030-00006.
7
Psychological consequences of false-positive screening mammograms in the UK.
Evid Based Med. 2013 Apr;18(2):54-61. doi: 10.1136/eb-2012-100608. Epub 2012 Aug 2.
8
Effect of false-positive mammograms on interval breast cancer screening in a health maintenance organization.
Ann Intern Med. 1999 Jul 6;131(1):1-6. doi: 10.7326/0003-4819-131-1-199907060-00002.
9
Additional double reading of screening mammograms by radiologic technologists: impact on screening performance parameters.
J Natl Cancer Inst. 2007 Aug 1;99(15):1162-70. doi: 10.1093/jnci/djm050. Epub 2007 Jul 24.
10
Predicting the cumulative risk of false-positive mammograms.
J Natl Cancer Inst. 2000 Oct 18;92(20):1657-66. doi: 10.1093/jnci/92.20.1657.

引用本文的文献

3
Breast cancer screening among Medicare Advantage enrollees with dementia.
BMC Health Serv Res. 2024 Mar 5;24(1):283. doi: 10.1186/s12913-024-10740-7.
4
Breast and prostate cancer screening rates by cognitive status in US older adults.
J Am Geriatr Soc. 2023 May;71(5):1558-1565. doi: 10.1111/jgs.18222. Epub 2023 Jan 6.
5
The prevalence of comorbidity in the lung cancer screening population: A systematic review and meta-analysis.
J Med Screen. 2023 Mar;30(1):3-13. doi: 10.1177/09691413221117685. Epub 2022 Aug 9.
7
Physical functioning, frailty and risks of locally-advanced breast cancer among older women.
Breast. 2022 Aug;64:19-28. doi: 10.1016/j.breast.2022.04.005. Epub 2022 Apr 14.
8
Mammography adherence in relation to function-related indicators in older women.
Prev Med. 2022 Jan;154:106869. doi: 10.1016/j.ypmed.2021.106869. Epub 2021 Nov 9.
9
Mammograms and Mortality: How Has the Evidence Evolved?
J Econ Perspect. 2021 Spring;35(2):119-140. doi: 10.1257/jep.35.2.119.
10
Frailty as a mortality predictor in older adults with COVID-19: A systematic review and meta-analysis of cohort studies.
Geriatr Nurs. 2021 Sep-Oct;42(5):983-992. doi: 10.1016/j.gerinurse.2021.06.003. Epub 2021 Jun 12.

本文引用的文献

2
Cancer screening in elderly patients: a framework for individualized decision making.
JAMA. 2001 Jun 6;285(21):2750-6. doi: 10.1001/jama.285.21.2750.
3
Treating nondementia illnesses in patients with dementia.
JAMA. 2000 Jun 28;283(24):3230-5. doi: 10.1001/jama.283.24.3230.
4
What is the right cancer screening rate?
Ann Intern Med. 2000 May 2;132(9):732-4. doi: 10.7326/0003-4819-132-9-200005020-00008.
5
American Cancer Society guidelines for the early detection of cancer.
CA Cancer J Clin. 2000 Jan-Feb;50(1):34-49. doi: 10.3322/canjclin.50.1.34.
6
Diagnostic testing following screening mammography in the elderly.
J Natl Cancer Inst. 1998 Sep 16;90(18):1389-92. doi: 10.1093/jnci/90.18.1389.
7
Screening for disease in older people.
J Gen Intern Med. 1998 Jun;13(6):424-5. doi: 10.1046/j.1525-1497.1998.00126.x.
8
Ductal carcinoma in situ of the breast.
Ann Intern Med. 1997 Dec 1;127(11):1013-22. doi: 10.7326/0003-4819-127-11-199712010-00013.
9
Program of All-inclusive Care for the Elderly (PACE): an innovative model of integrated geriatric care and financing.
J Am Geriatr Soc. 1997 Feb;45(2):223-32. doi: 10.1111/j.1532-5415.1997.tb04513.x.
10
Estimating treatment benefits for the elderly: the effect of competing risks.
Ann Intern Med. 1996 Mar 15;124(6):577-84. doi: 10.7326/0003-4819-124-6-199603150-00007.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验